Real-time enrollment status for this cardiac amyloidosis clinical trial
Current Status
Active, Not Recruiting
Checked: June 1, 2026 at 9:53 PM UTC
| NCT Number | NCT05184088 |
| Recruiting Status | Active, Not Recruiting |
| Condition | Cardiac Amyloidosis |
| Phase | Clinical Trial |
| Target Enrollment | 200 participants |
| Active Locations | 3 sites in the US |
| Sponsor | Life Molecular Imaging GmbH |
| Last Updated on CT.gov | May 26, 2026 (6 days ago) |
As of June 1, 2026: Clinical trial NCT05184088 is currently active_not_recruiting participants. This clinical trial study for cardiac amyloidosis is not currently accepting new participants at 3 locations across the United States. The study is sponsored by Life Molecular Imaging GmbH. This status information is automatically verified from the official ClinicalTrials.gov registry.
No, NCT05184088 is currently active_not_recruiting. The study may resume recruiting in the future.
This trial is recruiting at 3 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT05184088 was last updated 6 days ago (May 26, 2026). HelloStudys verifies this status automatically.